- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06811532
Assessing Perfusion of Osteotomized Scapula and Lat Flap
April 8, 2025 updated by: Danielle MacNeil, Western University, Canada
Assessing Perfusion of an Osteotomised Scapula and Latissimus Dorsi Chimeric Free Flap on the Thoracodorsal Artery
The gold standard for reconstruction of the jaw is the utilization of a bone free tissue transfer.
Scapula reconstruction is an excellent option for elderly patients, those with significant comorbidities and for complex defects with large soft tissue reconstructive requirements.
The scapula is supplied by the angular artery and circumflex scapula arteries.
No studies have shown with objective measures, the viability of the lateral border of the scapula bone supplied by either the angular artery or circumflex scapula arteries.
The aim of this observational study is to demonstrate with objective clinical measures, via SPY-Q software analysis, that the angular artery can adequately supply the scapula tip flap including with a single osteotomy giving two bone segments, in 30 patients who will undergo reconstructive head and neck surgery at LHSC.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of this follow-up observational study is to demonstrate with objective clinical measures via SPY-Q software analysis, that the angular artery can adequately supply the scapula tip flap including a single distal osteotomy segment.
30 patients undergoing mandible or maxillary reconstruction with the scapular tip flap will be included.
An osteotomy will be performed at up to 8cm from the scapular tip.
The adequacy of blood supply to the scapula tip flap after a distal osteotomy and the latissimus dorsi muscle component of the flap will be measured intraoperatively, using SPY-Q software analysis.
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Agnieszka Dzioba, PhD
- Phone Number: 519-685-8500
- Email: Agnieszka.Dzioba@lhsc.on.ca
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with advanced head and neck cancer, benign tumors of the jaw and osteoradionecrosis, scheduled for head and neck reconstructive surgery using the scapular tip flap at London Health Sciences Centre (LHSC).
Description
Inclusion Criteria:
• Adult patients (18 years and older) seen at the head and neck clinic at London Health Sciences Centre (LHSC)
- Planned to undergo a maxillary and/or mandibular reconstruction surgery with a scapular tip flap
Exclusion Criteria:
• Younger than 18 years of age
- History of failing microvascular flaps
- Hypersensitivity toward ICG or related substances (e.g., imaging agents), defined as (based on ICG product monograph): possibly life-threatening dizziness, severe itching, hives, nausea, difficulty breathing, rash, low blood pressure)
- Pregnant
- Breastfeeding
- Clinically apparent cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adequacy of blood perfusion of osteomized lateral border of the scapula bone supplied by the angular artery
Time Frame: Intra-operatively
|
To measure the adequacy of blood perfusion of osteotomised lateral border of the scapula bone supplied by the angular artery via SPY-Q analysis in patients undergoing a scapular tip flap for reconstruction of a jaw defect
|
Intra-operatively
|
|
Blood perfusion of osteomized lateral border of the scapula
Time Frame: Intra-operatively
|
To measure the adequacy of blood perfusion of osteotomised lateral border of the scapula bone supplied by the angular artery via SPY-Q analysis in patients undergoing a scapular tip flap for reconstruction of a jaw defect
|
Intra-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess flap viability
Time Frame: Intra-operatively; up to 10 days post-operatively
|
To evaluate whether scapular tip flaps with an osteotomy with adequate bone perfusion scores resulted in surgical success (flap viability)
|
Intra-operatively; up to 10 days post-operatively
|
|
Concordance between subjective and objective measure of blood perfusion
Time Frame: Intra-operatively; up to 10 days post-operatively
|
To assess the concordance between visual inspection of blood perfusion and SPY-Q analysis of blood perfusion
|
Intra-operatively; up to 10 days post-operatively
|
|
Blood perfusion of latissmus dorsi
Time Frame: Intra-operatively
|
To measure the adequacy of blood perfusion of the latissimus dorsi muscle component of the scapula flap via SPY-Q analysis
|
Intra-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Danielle MacNeil, MD, Department of Otolaryngology-Head & Neck Surgery, Western University Canada
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 7, 2025
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
March 30, 2027
Study Registration Dates
First Submitted
January 31, 2025
First Submitted That Met QC Criteria
January 31, 2025
First Posted (Actual)
February 6, 2025
Study Record Updates
Last Update Posted (Actual)
April 9, 2025
Last Update Submitted That Met QC Criteria
April 8, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 126223
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will be made available upon request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.